Globally, synovial sarcoma remains a rare but aggressive malignancy with a 5-year survival rate of 70% to 80% and a 10-year survival rate around 50%. Tumor size, location, and surgical margins are key ...
CSHL Professor David Spector and graduate student Disha Aggarwal have tracked levels of long non-coding RNA MALAT1 over the ...
Nearly 1 in 10 U.S. adults report having physician-diagnosed chronic head eczema, according to findings from a cross-sectional survey that were presented at the 2025 Fall Clinical Dermatology ...
NEW YORK and LONDON, Feb. 21, 2023 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (AKTX), a late-stage biotechnology company developing advanced therapies for autoimmune and inflammatory diseases, today ...
Clinical development programs for new drugs include an array of research conducted both before and after a drug’s initial approval by the Food and Drug Administration (FDA). Post-approval clinical ...